Scoring criteria for determining the safety of liver resection for malignant liver tumors

Table 7 Minimum residual liver volume based on various functional assessments

Authors	Publications	Functional assessments	Minimum residual LV			Mortality
			NL	CH, liver injury	LC
Shirabe et al[49]	J Am Coll Surg, 1999	Pathology (HCC, HB, or HC)	250 mL/m2 (40%)			8.8% (180 d)
Shoup et al[50]	J Gastrointest Surg, 2003	Pathology (NL, CRC metastasis alone)	25%	-	-	ND
Schindl et al[51]	Gut, 2005	Pathology (NL, 99% metastasis)	26.6%	-	-	ND
Ferrero et al[17]	World J Surg, 2007	Pathology (NL, liver injury)	26.5%	31%	-	0.8% (60 d)
van den Esschert et al[52]	J Gastrointest Surg, 2009	Pathology (CH, LC)	-	40%	50%	ND
Kishi et al[53]	Ann Surg, 2009	Pathology (NL)	20%	-	-	2.0% (30 d) 4.7% (60 d) 6.0% (90 d)
Suda et al[54]	Am J Surg, 2009	Pathology (NL, HCCa, GBCa, ICCa)	40%	-	-	8.1% (ND)
Vauthey et al[55]	HPB, 2010	Pathology (NL, liver injury, LC)	20%	30%	40%	ND
Gulielmi et al[56]	Dig Surg, 2012	Pathology (NL, steatosis, LC)	20%	30%	40%	ND
Hwang et al[16]	J Gastrointest Surg, 2015	Pathology (CH, LC)	-	35%	30%	0.8% (90 d)
Ribero et al[57]	J Am Coll Surg, 2016	Pathology (NL, HCCa alone)	30%	-	-	11% (90 d)
Our series	Hepatogastroenterolo-gy (in press)	ATIII, ICG15, GSA	35%-95%			2.3% (90 d)

LV: Liver volume; NL: Normal liver; CH: Chronic hepatitis; LC: Liver cirrhosis; HCC: Hepatocellular carcinoma; GBCa: Gallbladder cancer; ICCa: Intrahepatic cholangiocellular carcinoma; HCCa: Hilar cholangiocellular carcinoma; ATIII: Anti-thrombin III; ICG15: Indocyanine green retention rate at 15 min; GSA: 99m Tc-galactosyl human serum albumin scintigraphy; ND: Not describe.